Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome

NCT06801249 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Adrenal Incidentalomas
Cushing Syndrome

Interventions

DRUG: Metarapone
DRUG: Standardized antihypertensive therapy

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna